BTIG Downgrades Zoom Video Comms to Neutral

BTIG analyst Matthew Vliet downgrades Zoom Video Comms (NASDAQ:ZM) from Buy to Neutral.

BTIG analyst Matthew Vliet downgrades Zoom Video Comms (NASDAQ:ZM) from Buy to Neutral.

Total
0
Shares
Related Posts
Read More

Avidity Biosciences Announces Topline Data From AOC 1001 Phase 1/2 MARINA Trial Demonstrating Functional Improvement, Disease Modification And Favorable Safety And Tolerability Profile In People Living With Myotonic Dystrophy Type 1

Topline data presented at AAN annual meeting showed AOC 1001 achieved directional improvements in multiple functional endpoint assessments - myotonia (vHOT), measures of strength (total QMT) and mobility (10mWRT, Timed

RNA